Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management Carla Maria Boquimpani; André Neder Ramires Abdo; Denise Pires Martins; Luciana Britto de Abreu Lima; Mayde Seadi Torriani; Israel Bendit;

REVERSAL OF ACCELERATED PHASE CML WITH HIGH BLAST COUNT FOLLOWING 5+2 CHEMOTHERAPY AND DASATINIB: A CASE REPORT Bü¿ra Akdo¿an; Ali Turunç; Birol Güvenç;

PDCD1 VARIANTS ARE INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA Matheus Yung Perin; Daniele Daiane Affonso; Carlos Takahiro Chone; Gustavo Jacob Lourenço; Carmen Silvia Passos Lima;